Pancreaticoduodenectomy for nonperiampullary primary tumors

Lawrence Harrison, Nipun Merchant, Alfred M. Cohen, Murray F. Brennan

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

INTRODUCTION: This review was performed to evaluate the outcome of patients undergoing pancreaticoduodenectomy (PD) for isolated metastatic or locally advanced nonperiampullary tumors at a single institution over a 13- year period. METHODS: Between 1983 and 1996, patients undergoing PD for metastatic or locally advanced nonperiampullary malignancies were identified. Medical records were reviewed and outcome factors and survival data analyzed. RESULTS: Eighteen patients were identified. The primary tumor histopathology included colon (n = 7), gastric (n = 4), renal cell (n = 3), lung (n = 2), bladder (n = 1), and melanoma (n = 1). The median length of hospital stay was 15 days (6 to 48) with one perioperative death (5.5%). The median tumor size was 5.5 cm (0.8 to 11.5), and 7 patients had positive peripancreatic lymph nodes. The median survival was 40 months, with a 5-year survival of 35%. CONCLUSIONS: Pancreaticoduodenectomy for nonperiampullary malignancy is infrequently indicated. However, in the absence of widely metastatic disease, PD should be considered for locally advanced tumors or isolated metastatic malignancy.

Original languageEnglish (US)
Pages (from-to)393-395
Number of pages3
JournalAmerican Journal of Surgery
Volume174
Issue number4
DOIs
StatePublished - Oct 1 1997
Externally publishedYes

Fingerprint

Pancreaticoduodenectomy
Neoplasms
Survival
Length of Stay
Medical Records
Melanoma
Stomach
Colon
Urinary Bladder
Lymph Nodes
Kidney
Lung

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Harrison, Lawrence ; Merchant, Nipun ; Cohen, Alfred M. ; Brennan, Murray F. / Pancreaticoduodenectomy for nonperiampullary primary tumors. In: American Journal of Surgery. 1997 ; Vol. 174, No. 4. pp. 393-395.
@article{38acaed2b8be4208a17e2e3f22f9d7bb,
title = "Pancreaticoduodenectomy for nonperiampullary primary tumors",
abstract = "INTRODUCTION: This review was performed to evaluate the outcome of patients undergoing pancreaticoduodenectomy (PD) for isolated metastatic or locally advanced nonperiampullary tumors at a single institution over a 13- year period. METHODS: Between 1983 and 1996, patients undergoing PD for metastatic or locally advanced nonperiampullary malignancies were identified. Medical records were reviewed and outcome factors and survival data analyzed. RESULTS: Eighteen patients were identified. The primary tumor histopathology included colon (n = 7), gastric (n = 4), renal cell (n = 3), lung (n = 2), bladder (n = 1), and melanoma (n = 1). The median length of hospital stay was 15 days (6 to 48) with one perioperative death (5.5{\%}). The median tumor size was 5.5 cm (0.8 to 11.5), and 7 patients had positive peripancreatic lymph nodes. The median survival was 40 months, with a 5-year survival of 35{\%}. CONCLUSIONS: Pancreaticoduodenectomy for nonperiampullary malignancy is infrequently indicated. However, in the absence of widely metastatic disease, PD should be considered for locally advanced tumors or isolated metastatic malignancy.",
author = "Lawrence Harrison and Nipun Merchant and Cohen, {Alfred M.} and Brennan, {Murray F.}",
year = "1997",
month = "10",
day = "1",
doi = "10.1016/S0002-9610(97)00121-9",
language = "English (US)",
volume = "174",
pages = "393--395",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "4",

}

Pancreaticoduodenectomy for nonperiampullary primary tumors. / Harrison, Lawrence; Merchant, Nipun; Cohen, Alfred M.; Brennan, Murray F.

In: American Journal of Surgery, Vol. 174, No. 4, 01.10.1997, p. 393-395.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pancreaticoduodenectomy for nonperiampullary primary tumors

AU - Harrison, Lawrence

AU - Merchant, Nipun

AU - Cohen, Alfred M.

AU - Brennan, Murray F.

PY - 1997/10/1

Y1 - 1997/10/1

N2 - INTRODUCTION: This review was performed to evaluate the outcome of patients undergoing pancreaticoduodenectomy (PD) for isolated metastatic or locally advanced nonperiampullary tumors at a single institution over a 13- year period. METHODS: Between 1983 and 1996, patients undergoing PD for metastatic or locally advanced nonperiampullary malignancies were identified. Medical records were reviewed and outcome factors and survival data analyzed. RESULTS: Eighteen patients were identified. The primary tumor histopathology included colon (n = 7), gastric (n = 4), renal cell (n = 3), lung (n = 2), bladder (n = 1), and melanoma (n = 1). The median length of hospital stay was 15 days (6 to 48) with one perioperative death (5.5%). The median tumor size was 5.5 cm (0.8 to 11.5), and 7 patients had positive peripancreatic lymph nodes. The median survival was 40 months, with a 5-year survival of 35%. CONCLUSIONS: Pancreaticoduodenectomy for nonperiampullary malignancy is infrequently indicated. However, in the absence of widely metastatic disease, PD should be considered for locally advanced tumors or isolated metastatic malignancy.

AB - INTRODUCTION: This review was performed to evaluate the outcome of patients undergoing pancreaticoduodenectomy (PD) for isolated metastatic or locally advanced nonperiampullary tumors at a single institution over a 13- year period. METHODS: Between 1983 and 1996, patients undergoing PD for metastatic or locally advanced nonperiampullary malignancies were identified. Medical records were reviewed and outcome factors and survival data analyzed. RESULTS: Eighteen patients were identified. The primary tumor histopathology included colon (n = 7), gastric (n = 4), renal cell (n = 3), lung (n = 2), bladder (n = 1), and melanoma (n = 1). The median length of hospital stay was 15 days (6 to 48) with one perioperative death (5.5%). The median tumor size was 5.5 cm (0.8 to 11.5), and 7 patients had positive peripancreatic lymph nodes. The median survival was 40 months, with a 5-year survival of 35%. CONCLUSIONS: Pancreaticoduodenectomy for nonperiampullary malignancy is infrequently indicated. However, in the absence of widely metastatic disease, PD should be considered for locally advanced tumors or isolated metastatic malignancy.

UR - http://www.scopus.com/inward/record.url?scp=0030769512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030769512&partnerID=8YFLogxK

U2 - 10.1016/S0002-9610(97)00121-9

DO - 10.1016/S0002-9610(97)00121-9

M3 - Article

C2 - 9337160

AN - SCOPUS:0030769512

VL - 174

SP - 393

EP - 395

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 4

ER -